
Oxytocin Acetate is a synthetic version of the naturally occurring cyclic nonapeptide. Its chemical structure is represented as Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2, with a critical disulfide bridge between the two cysteine residues (Cys1 and Cys6).
The "Acetate" Formulation: In its raw API form, Oxytocin is typically provided as an acetate salt. This formulation is chosen for its superior stability and solubility in aqueous solutions compared to the free base.
Synthetic vs. Natural: While early medical history relied on bovine or porcine pituitary extracts, modern Oxytocin Acetate is produced via Solid-Phase Peptide Synthesis (SPPS) or Liquid-Phase Peptide Synthesis (LPPS). Synthetic production is mandatory in modern medicine to eliminate the risk of contamination with other pituitary hormones (like Vasopressin/ADH) and to ensure that the product is free from bovine spongiform encephalopathy (BSE) and other animal-derived pathogens.
Structural Integrity: The cyclic nature of the molecule—the "ring" formed by the disulfide bond—is absolutely vital for its biological activity. If this bond is reduced or broken, the molecule loses its ability to bind to the Oxytocin Receptor (OXTR).
Oxytocin Acetate functions as a potent agonist of the G-protein coupled Oxytocin Receptor (OXTR), which is primarily located in the smooth muscle cells of the uterus and the myoepithelial cells of the mammary glands.
A. Uterine Contraction (The Ferguson Reflex):
When Oxytocin binds to the receptors in the myometrium (uterine muscle), it triggers a cascade of intracellular signals:
Phospholipase C Activation: Binding activates phospholipase C, which leads to the production of inositol trisphosphate (IP3).
Calcium Release: IP3 triggers the release of sequestered calcium ions from the sarcoplasmic reticulum into the cytoplasm.
Myosin Light Chain Kinase: The increased calcium concentration activates myosin light chain kinase, leading to the contraction of the smooth muscle fibers.
In a clinical setting, this results in rhythmic, coordinated contractions that facilitate the expulsion of the fetus during labor.
B. The Milk Ejection Reflex (Let-Down):
In the mammary glands, Oxytocin acts on the myoepithelial cells surrounding the alveoli. When these cells contract under the influence of Oxytocin, milk is squeezed from the alveolar lumen into the larger ducts and eventually into the teat cistern. It is important to note that Oxytocin does not stimulate milk production (which is the role of Prolactin); it only stimulates the ejection of already synthesized milk.
Oxytocin Acetate is an indispensable tool in livestock management, equine medicine, and small animal obstetrics.
In modern pig farming, Oxytocin is frequently used to assist sows during prolonged farrowing. By strengthening uterine contractions, it reduces the interval between the births of piglets, which is crucial for preventing stillbirths caused by hypoxia (oxygen deprivation). It is also used to treat "Metritis-Mastitis-Agalactia" (MMA) syndrome, helping to clear the uterus of post-birth debris and stimulating milk flow for the litter.
In high-producing dairy cows, Oxytocin is used as an adjunct therapy for mastitis. By ensuring the "complete let-down" of milk, it helps flush out infected milk and bacteria from the udder, enhancing the effectiveness of intramammary antibiotics. It is also used for "nervous" heifers who fail to let down milk due to the stress of early lactation.
A retained placenta in a mare is a medical emergency that can lead to laminitis and systemic sepsis. Oxytocin Acetate is the first-line treatment, administered in small, frequent doses or as a slow intravenous drip to stimulate the gentle contractions necessary to expel the membranes without causing uterine rupture.
Oxytocin is used in cases of Primary Uterine Inertia, where the uterus fails to contract sufficiently to begin labor. However, veterinarians must first ensure the birth canal is not obstructed (dystocia), as administering Oxytocin against an obstruction can be fatal for the mother.
As a peptide, Oxytocin Acetate is inherently fragile. Its shelf life and potency are highly sensitive to environmental factors:
Temperature Sensitivity: Oxytocin API and finished injectables typically require "Cold Chain" management (
2−8∘C2−8∘C
). Exposure to high temperatures leads to the deamidation of the asparagine (Asn) and glutamine (Gln) residues, rendering the hormone inactive.
pH Stability: The molecule is most stable at a slightly acidic pH (typically 3.0 to 5.0). Deviations from this range can lead to the oxidation of the disulfide bridge.
Aggregation: Peptides have a tendency to aggregate or "stick" to the surface of glass or plastic containers. High-quality formulations often include stabilizers like chlorobutanol or specialized buffers to prevent this loss of potency.
For pharmaceutical manufacturers and veterinary distributors, sourcing Oxytocin Acetate requires a deep audit of the supplier’s peptide synthesis capabilities. Key benchmarks include:
Peptide Purity (HPLC): The industry standard for Oxytocin Acetate API is a purity of
≥98%≥98%
. Any impurities—specifically related peptides or truncated sequences—can cause unpredictable side effects or reduce efficacy.
Mass Spectrometry (MS) Verification: A reliable supplier must provide MS data to prove the exact molecular weight and the correct amino acid sequence.
TFA Content: Trifluoroacetic acid (TFA) is often used in peptide synthesis. High-quality API must have the TFA content removed or strictly limited to safe levels through ion-exchange chromatography.
Bacterial Endotoxin Testing: Because Oxytocin is an injectable drug, the API must be tested for endotoxins (LAL test) to ensure it does not cause a pyrogenic (fever) response in the animal.
Water Content (Karl Fischer): Peptides are hygroscopic. Precise control of the water content is necessary for accurate dosing during the formulation of the finished dosage form.
Arshine Vet, the dedicated animal health arm of the Arshine Group, is a premier global service provider specializing in high-end veterinary hormones and peptides, including Oxytocin Acetate.
The synthesis of peptides is a sophisticated science that leaves no room for error. At Arshine Vet, we bridge the gap between advanced biotechnology and practical veterinary application. We source our Oxytocin Acetate from manufacturers who utilize state-of-the-art solid-phase synthesis platforms, ensuring that every milligram of product meets the rigorous standards of the USP (United States Pharmacopeia) and EP (European Pharmacopoeia).
The Arshine Advantage:
Quality Assurance: Every batch of Oxytocin Acetate undergoes a comprehensive "Arshine Inspection," including HPLC purity checks, amino acid analysis, and sterility testing.
Cold Chain Logistics: We understand the fragility of peptides. Our logistics team is expert in maintaining the cold chain from the factory to your warehouse, utilizing specialized packaging and temperature-monitoring technology.
Global Regulatory Support: We provide full documentation, including DMFs and GMP certificates, to facilitate the smooth registration of your finished products in global markets.
Technical Consulting: Our team of veterinarians and chemists can assist you in optimizing your Oxytocin formulations for maximum stability and efficacy.
At Arshine Vet, we are more than just a supplier; we are your strategic partner in animal reproductive health. By providing the highest quality Oxytocin Acetate, we help you ensure safer births, healthier livestock, and a more productive agricultural future.
For technical dossiers, price quotations, or to discuss your specific peptide requirements, please contact the Arshine Vet professional team:
Add: Block 14, No.100, Luyun Road, Changsha 410205, Hunan, China.
Email: info@arshinevet.com
WeChat: +8618874001228
WhatsApp: +8615697311407
Tel: 86-731-82294958
Product Link:https://arshinevet.com/product-detail/oxytocin-acetate-usp-bp-ep
Add: Block 14, No.100, Luyun Road, Changsha 410205, Hunan, China.
Email: info@arshinevet.com
WeChat: +8618874001228
WhatsApp: +8615697311407
Tel:86-731-82294958